PHILADELPHIA, March 12 /PRNewswire/ -- On the occasion of World Kidney Day, Kibow Biotech, Inc. is pleased to announce that it will soon be introducing a breakthrough probiotic formulation as a scientifically formulated and clinically tested dietary supplement product, which, when taken regularly as instructed, could help maintain healthy kidney function.
Kibow Biotech, Inc. is an 11 year-old, Philadelphia suburban-based biotech company with unique and pioneering probiotic-based dietary supplements for supporting renal health.
The Company's lead product, Kibow Biotics(R) has its own self-acclaimed US FDA GRAS status. GRAS is an acronym for Generally Recognized As Safe and means that the substance is generally recognized, among qualified scientific and medical experts, as having been adequately shown to be safe under the conditions of its intended use.
Although Kibow is currently conducting a pilot scale human clinical study of this formulation in five different countries, Kibow Biotics(R) will be introduced as a dietary supplement rather than a drug to US consumers to help maintain healthy kidney function.
Dr. Natarajan Ranganathan, Interim CEO and VP Research and Development, stated, "By offering an affordable, readily available and easy-to-administer dietary supplement product in the USA, Kibow aims to make Kibow Biotics accessible to all those who suffer from kidney problems in other countries worldwide according to individual countries' governmental rules and regulatory authorities."
Kibow Biotics will be available online (http://www.kibow.com) in the USA starting on April 3, 2009.
For more information, visit http://www.kibow.com
This press release contains forward-looking statements that refl
|SOURCE Kibow Biotech, Inc.|
Copyright©2009 PR Newswire.
All rights reserved